Reversal of human cytomegalovirus major immediate-early enhancer/promoter silencing in quiescently infected cells via the cyclic AMP signaling pathway.
about
Neuropathogenesis of congenital cytomegalovirus infection: disease mechanisms and prospects for interventionImmunobiology of congenital cytomegalovirus infection of the central nervous system—the murine cytomegalovirus modelCyclin-dependent kinase activity controls the onset of the HCMV lytic cycleCytomegalovirus latency and reactivation: recent insights into an age old problem.Mouse embryonic stem cells inhibit murine cytomegalovirus infection through a multi-step processPhorbol ester-induced human cytomegalovirus major immediate-early (MIE) enhancer activation through PKC-delta, CREB, and NF-kappaB desilences MIE gene expression in quiescently infected human pluripotent NTera2 cells.Schizophrenia susceptibility genes directly implicated in the life cycles of pathogens: cytomegalovirus, influenza, herpes simplex, rubella, and Toxoplasma gondii.Mitogen and stress activated kinases act co-operatively with CREB during the induction of human cytomegalovirus immediate-early gene expression from latency.A temporal gate for viral enhancers to co-opt Toll-like-receptor transcriptional activation pathways upon acute infectionContribution of the Major ND10 Proteins PML, hDaxx and Sp100 to the Regulation of Human Cytomegalovirus Latency and Lytic Replication in the Monocytic Cell Line THP-1.Human Cytomegalovirus US28 Is Important for Latent Infection of Hematopoietic Progenitor Cells.Epigenetic control of cytomegalovirus latency and reactivation.The CREB site in the proximal enhancer is critical for cooperative interaction with the other transcription factor binding sites to enhance transcription of the major intermediate-early genes in human cytomegalovirus-infected cells.Promyelocytic leukemia-nuclear body proteins: herpesvirus enemies, accomplices, or both?Maintenance of large numbers of virus genomes in human cytomegalovirus-infected T98G glioblastoma cellsPluripotent stem cells are protected from cytomegalovirus infection at multiple points: implications of a new pathogenesis for congenital anomaly caused by cytomegalovirus.Regulation of human cytomegalovirus transcription in latency: beyond the major immediate-early promoterHuman cytomegalovirus manipulation of latently infected cells.The intimate relationship between human cytomegalovirus and the dendritic cell lineage.Inhibition of inflammatory interleukin-6 activity via extracellular signal-regulated kinase-mitogen-activated protein kinase signaling antagonizes human cytomegalovirus reactivation from dendritic cells.A myeloid progenitor cell line capable of supporting human cytomegalovirus latency and reactivation, resulting in infectious progeny.The activator protein 1 binding motifs within the human cytomegalovirus major immediate-early enhancer are functionally redundant and act in a cooperative manner with the NF-{kappa}B sites during acute infectionThe alphaherpesvirus US3/ORF66 protein kinases direct phosphorylation of the nuclear matrix protein matrin 3Breaking human cytomegalovirus major immediate-early gene silence by vasoactive intestinal peptide stimulation of the protein kinase A-CREB-TORC2 signaling cascade in human pluripotent embryonal NTera2 cells.Human cytomegalovirus gene expression is silenced by Daxx-mediated intrinsic immune defense in model latent infections established in vitro.Differential control of retrovirus silencing in embryonic cells by proteasomal regulation of the ZFP809 retroviral repressor.Cellular and viral control over the initial events of human cytomegalovirus experimental latency in CD34+ cellsPolycomb repressive complex 2 silences human cytomegalovirus transcription in quiescent infection models.Molecular Determinants and the Regulation of Human Cytomegalovirus Latency and Reactivation
P2860
Q24570124-3523BBCB-FBC2-497B-94A6-4CD824180136Q27026924-2FB090B0-53DE-4ED7-B379-8FAC464753C6Q28475459-A8C2D6A1-AA54-4B70-A5D3-981D394BA7C0Q33761454-0863AEA1-4475-4DA8-A3E1-A24F4BD36D7EQ33846984-43DD6EA9-CB24-4D7E-A464-90587F35ACABQ34055456-BCC242CD-2075-4D82-8370-B3F7FDC08E9FQ34786420-C7E36B74-7899-455F-837C-D7A083909F4DQ35191037-DB653C32-864C-4441-9DF0-49B9BF3F1864Q35347846-6CCCA598-116B-4591-93BB-FC5BC4286851Q35808649-6B25E6D7-30E2-4DD5-947E-93CD1AD60C61Q36736662-59E55B3B-AD3D-40C0-9ABB-312132818B2FQ37015743-4D05B127-36DF-4CA5-96E9-8CC0C061052DQ37333784-5A3F2C24-A71D-4410-AFAA-E592B1EADE94Q37599336-A679A89F-878B-4827-9D77-3F3767B1F9A8Q37713554-33B3DF53-393F-49B2-B25B-55D133DC91D3Q38038303-2EF20264-D5AD-477D-BB2C-8CBB75769C27Q38111995-88B715DC-B723-492A-9ECF-E2217DDAE85EQ38166925-D2AA3021-0133-49B5-96F5-7B4A8C13357FQ38242199-D253F4A2-EB76-4BBA-937D-37B748DA027CQ38960892-FB5F6423-5C72-47FF-84C7-4B1C49EE4491Q39320231-AB426556-00CF-40EF-ACE0-D274335D85BDQ39627859-66CE8A95-2B98-4469-8B5B-EDFEBAB409A4Q39641787-ED440E9F-AB46-4129-B4D1-8D61D72BD4AAQ39860663-923BB30A-0278-4393-9551-52395E848347Q40114561-1A3B3FDB-2A8D-4A4D-8EF5-72928205F808Q40367498-A76AE61E-ED44-4237-89A6-46A324B8711CQ40756627-377F436C-119A-4BD4-A9B8-37934BAB4BCCQ41813781-8CFC8ADD-C7C8-446F-8E2A-1C29A83BE335Q58734475-5082F743-72B2-4A3B-91BE-73C0143030BD
P2860
Reversal of human cytomegalovirus major immediate-early enhancer/promoter silencing in quiescently infected cells via the cyclic AMP signaling pathway.
description
2007 nî lūn-bûn
@nan
2007年の論文
@ja
2007年論文
@yue
2007年論文
@zh-hant
2007年論文
@zh-hk
2007年論文
@zh-mo
2007年論文
@zh-tw
2007年论文
@wuu
2007年论文
@zh
2007年论文
@zh-cn
name
Reversal of human cytomegalovi ...... cyclic AMP signaling pathway.
@ast
Reversal of human cytomegalovi ...... cyclic AMP signaling pathway.
@en
type
label
Reversal of human cytomegalovi ...... cyclic AMP signaling pathway.
@ast
Reversal of human cytomegalovi ...... cyclic AMP signaling pathway.
@en
prefLabel
Reversal of human cytomegalovi ...... cyclic AMP signaling pathway.
@ast
Reversal of human cytomegalovi ...... cyclic AMP signaling pathway.
@en
P2093
P2860
P356
P1433
P1476
Reversal of human cytomegalovi ...... cyclic AMP signaling pathway.
@en
P2093
Allen W Wu
Eric E Tibesar
Janet I Andrews
Jeffery L Meier
Michael J Keller
Patrick W McGonagill
P2860
P304
P356
10.1128/JVI.01524-06
P407
P577
2007-02-14T00:00:00Z